AIDS Immunopathology Unit, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain.
AIDS Rev. 2011 Jul-Sep;13(3):149-60.
The RNA interference pathway is a mechanism to regulate gene expression that acts in mammalian antiviral immunity as a complement of interferon- and cytokine-based innate immunity. RNA interference has been proposed as an ancient mechanism against viruses since several components of this system show an effect against viral replication. In fact, protein effectors of this pathway, as well as synthesized microRNA, act against HIV-1, exerting a partial control over HIV-1 latency and replication. Conversely, HIV-1 may counteract this antiviral cell response through two major lines of attack: first, its main regulator Tat suppresses the cellular RNA interference pathway; and second, the virus synthesizes viral microRNA that alter specific cellular functions to enhance HIV-1 replication. As a result of this complex interaction, the microRNA profile in an HIV-1-infected cell is deeply modified. One key application of all this knowledge is the development of pharmacological treatment since microRNA expression can be manipulated and artificial small interference RNA can be delivered into the infected cell to inhibit viral replication. This strategy, combined with current antiretroviral therapy, could be valuable in controlling HIV-1 replication in infected cells.
RNA 干扰途径是一种调节基因表达的机制,在哺乳动物抗病毒免疫中作为干扰素和细胞因子为基础的先天免疫的补充。RNA 干扰被认为是一种古老的抗病毒机制,因为该系统的几个组成部分对病毒复制有影响。事实上,该途径的蛋白效应因子,以及合成的 microRNA,对 HIV-1 发挥作用,对 HIV-1 的潜伏期和复制产生部分控制。相反,HIV-1 可能通过两种主要的攻击方式来对抗这种抗病毒的细胞反应:首先,其主要调节因子 Tat 抑制细胞 RNA 干扰途径;其次,病毒合成病毒 microRNA,改变特定的细胞功能,以增强 HIV-1 的复制。由于这种复杂的相互作用,HIV-1 感染细胞中的 microRNA 谱被深度修饰。所有这些知识的一个关键应用是开发药理学治疗,因为可以操纵 microRNA 的表达,并将人工小干扰 RNA 递送到感染的细胞中以抑制病毒复制。这种策略与当前的抗逆转录病毒治疗相结合,可能有助于控制感染细胞中 HIV-1 的复制。